{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:45Z","timestamp":1788499005268,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To evaluate the long-term efficacy and safety of the\n                      <jats:italic>Astragalus-Salvia miltiorrhiza<\/jats:italic>\n                      (ASM) botanical drug pair as an adjunctive therapy for stable coronary artery disease (SCAD) and to develop a prognostic nomogram for frequent readmissions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This real-world retrospective cohort study included 686 SCAD patients (343 receiving ASM plus standard care and 343 receiving standard care alone). Inverse probability of treatment weighting (IPTW) was applied to balance covariates. After a 5-year follow-up, biochemical parameters, primarily low-density lipoprotein cholesterol (LDL-C), and safety profiles were compared. Furthermore, multivariable logistic regression was used to construct a nomogram predicting frequent readmissions (\u22653 times), and symptom networks were analyzed via the Apriori algorithm to evaluate symptom alleviation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At the 5-year follow-up, compared to controls, the ASM group exhibited significantly reduced LDL-C, total cholesterol (TC), triglycerides (TG), heart rate, and monocytes, alongside elevated high-density lipoprotein cholesterol (HDL-C), free triiodothyronine (FT3), and free thyroxine (FT4) (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Hepatic and renal functions remained unaffected (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;gt; 0.05). Notably, stroke history emerged as the primary independent risk factor (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) for frequent readmissions. The nomogram integrating stroke history, age, diastolic blood pressure, FT3, and hemoglobin demonstrated excellent calibration. Symptom network analysis identified \u201cchest tightness\u201d as the core symptom alleviated by ASM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ASM adjunctive therapy safely improves lipid profiles, stabilizes heart rate, and alleviates chest tightness in SCAD. The proposed nomogram offers a reliable tool for risk stratification, providing real-world evidence to optimize the integrative management of SCAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/itmctr.ccebtcm.org.cn\/mgt\/dashboard<\/jats:ext-link>\n                      , identifier TMCTR2025000058.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1898253","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:20Z","timestamp":1788496040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term efficacy of the Astragalus-Salvia miltiorrhiza botanical drug pair in stable coronary artery disease and a nomogram for predicting frequent hospitalization: a real-world retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Liwen","family":"Fu","sequence":"first","affiliation":[{"name":"Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiu","family":"Han","sequence":"additional","affiliation":[{"name":"Rehabilitation Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu","family":"Gao","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyan","family":"Long","sequence":"additional","affiliation":[{"name":"Xinyang Clinic","place":["Hangzhou, Zhejiang Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhu","family":"Liu","sequence":"additional","affiliation":[{"name":"Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]},{"name":"Acupuncture & Wellness","place":["New York, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlun","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/cn400140e","article-title":"Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models","volume":"4","author":"Buenafe","year":"2013","journal-title":"ACS chemical neuroscience"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0162414","DOI":"10.1371\/journal.pone.0162414","article-title":"Tanshinone IIA modulates low density lipoprotein uptake via down-regulation of PCSK9 gene expression in HepG2 cells","volume":"11","author":"Chen","year":"2016","journal-title":"PloS one"},{"key":"B3","doi-asserted-by":"publisher","first-page":"24308","DOI":"10.1021\/acsomega.3c09983","article-title":"Quantitative proteomics reveal the role of matrine in regulating lipid metabolism","volume":"9","author":"Feng","year":"2024","journal-title":"ACS omega"},{"key":"B4","first-page":"1880","article-title":"Traditional Chinese Medicine Diagnosis and Treatment Guidelines for Stable Angina Pectoris of Coronary Heart Disease","volume":"60","year":"2019","journal-title":"J Tradit Chin Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet (London, England)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.13288\/j.11-2166\/r.2025.06.010","article-title":"Construction and application evaluation of a risk prediction model for rehospitalization in patients with stable angina pectoris due to coronary heart disease: a prospective study based on real-world clinical data","volume":"66","author":"Han","year":"2025","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.12659\/msm.905544","article-title":"Effects of an enriched extract of paeoniflorin, a monoterpene glycoside used in Chinese herbal medicine, on cholesterol metabolism in a hyperlipidemic rat model","volume":"23","author":"Hu","year":"2017","journal-title":"Medical science monitor International medical journal of experimental and clinical research"},{"key":"B8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fcvm.2023.1137778","article-title":"Research progress on the mechanism of astragalus and its active components in the prevention and treatment of atherosclerosis by regulating lipid metabolism","volume":"63","author":"Li","year":"2023","journal-title":"Shandong Yi Yao"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1137778","DOI":"10.3389\/fcvm.2023.1137778","article-title":"Risk prediction model for major adverse cardiovascular events (MACE) during hospitalization in patients with coronary heart disease based on myocardial energy metabolic substrate","volume":"10","author":"Li","year":"2023","journal-title":"Frontiers in cardiovascular medicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.13862\/j.cn43-1446\/r.2024.06.026","article-title":"Research progress on the pathogenesis of stable coronary artery disease and its treatment with traditional Chinese medicine","volume":"30","author":"Ni","year":"2024","journal-title":"Zhong Yi Yao Dao Bao"},{"key":"B11","first-page":"107","article-title":"Progress in revascularization strategies for stable coronary artery disease: interpretation of the 2018 Chinese guidelines for the diagnosis and treatment of stable coronary artery disease","volume":"19","author":"Shen","year":"2019","journal-title":"Xin Nao Xue Guan Bing Fang Zhi"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2634484","DOI":"10.1080\/07853890.2026.2634484","article-title":"Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events","volume":"58","author":"Vuorio","year":"2026","journal-title":"Annals of medicine"},{"key":"B13","first-page":"101","article-title":"Research progress of traditional Chinese medicine in the treatment of atherosclerotic cardiovascular disease from Qi deficiency and blood stasis","volume":"23","author":"Wang","year":"2025","journal-title":"China Pharmacy and Pharmaceutical Knowledge Database"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2147\/CIA.S325385","article-title":"Development and validation of a risk nomogram model for predicting revascularization after percutaneous coronary intervention in patients with acute coronary syndrome","volume":"16","author":"Xiao","year":"2021","journal-title":"Clinical Interventions in aging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.16254\/j.cnki.53-1120\/r.2025.07.003","article-title":"Theoretical discussion on the treatment of stable coronary artery disease by the method of harmonizing Qi and blood","volume":"46","author":"Xin","year":"2025","journal-title":"Yunnan Zhong Yi Zhong Yao Za Zhi."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.16367\/j.issn.1003-5028.2021.08.0291","article-title":"Research progress on herb pairs of Astragalus combined with Qi-replenishing, blood-activating, and blood-nourishing herbs","volume":"41","author":"Ye","year":"2021","journal-title":"Henan Zhong Yi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.13375\/j.cnki.wcjps.2025.01.021","article-title":"Research progress on the Astragalus-Salvia herb pair in the prevention and treatment of cardiovascular diseases","volume":"40","author":"Yu","year":"2025","journal-title":"Hua Xi Yao Xue Za Zhi"},{"key":"B18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/01.mol.0000180165.70077.ee","article-title":"Chromatin modification by lipids and lipoprotein components: an initiating event in atherogenesis?","volume":"16","author":"Zaina","year":"2005","journal-title":"Current opinion in lipidology"},{"key":"B19","volume-title":"Study on the Mechanism of Astragalus propinquus Schischkin-Salvia Miltiorrhiza Bunge in Promoting Angiogenesis in Qi-Deficiency and Blood-Stasis Type of Stable Coronary Heart Disease Based on Qi-Boosting and Blood-Activating Treatment Method","author":"Zhang","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12872-023-03496-1","article-title":"MiR-483-5p downregulation alleviates ox-LDL induced endothelial cell injury in atherosclerosis","volume":"23","author":"Zhu","year":"2023","journal-title":"BMC cardiovascular disorders"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1898253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:27:26Z","timestamp":1788496046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1898253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":20,"alternative-id":["10.3389\/fphar.2026.1898253"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1898253","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1898253"}}